Maged Ghada, Abdelsamed Menna A, Wang Hongjun, Lotfy Ahmed
Department of Biochemistry, Faculty of Science, Alexandria University, Alexandria, Egypt.
Biotechnology and Life Sciences Department, Faculty of Postgraduate studies for Advanced Sciences, Beni-Suef University, Beni Suef, Egypt.
Stem Cell Res Ther. 2024 Apr 22;15(1):112. doi: 10.1186/s13287-024-03722-3.
Mesenchymal stem/stromal cells (MSCs) are a promising therapeutic tool in cell therapy and tissue engineering because of their multi-lineage differentiation capacity, immunomodulatory effects, and tissue protective potential. To achieve optimal results as a therapeutic tool, factors affecting MSC potency, including but not limited to cell source, donor age, and cell batch, have been investigated. Although the sex of the donor has been attributed as a potential factor that can influence MSC potency and efficacy, the impact of donor sex on MSC characteristics has not been carefully investigated. In this review, we summarize published studies demonstrating donor-sex-related MSC heterogeneity and emphasize the importance of disclosing donor sex as a key factor affecting MSC potency in cell therapy.
间充质干/基质细胞(MSCs)因其多谱系分化能力、免疫调节作用和组织保护潜力,在细胞治疗和组织工程中是一种很有前景的治疗工具。为了作为一种治疗工具取得最佳效果,人们已经对影响MSCs效能的因素进行了研究,这些因素包括但不限于细胞来源、供体年龄和细胞批次。尽管供体性别被认为是可能影响MSCs效能和疗效的一个潜在因素,但供体性别对MSCs特性的影响尚未得到仔细研究。在这篇综述中,我们总结了已发表的证明与供体性别相关的MSCs异质性的研究,并强调了披露供体性别作为影响细胞治疗中MSCs效能的关键因素的重要性。